☆ 4.6 Review

Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: The Next Threat after Viral Hepatitis

DIAGNOSTICS (2023)

Related references

Note: Only part of the references are listed.

Article Gastroenterology & Hepatology

Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database

Alessandro Vitale et al.

Summary: This study compared patients with MAFLD and non-MAFLD who had hepatocellular carcinoma (HCC) in Italy. It found that the proportion of MAFLD in HCC patients was increasing over time and is expected to surpass non-MAFLD in the future. Despite a later cancer stage at diagnosis, MAFLD HCC patients had a lower risk of HCC-related death, suggesting reduced cancer aggressiveness.

GUT (2023)

Add to Collection

Article Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region

Janus Ong et al.

CLINICS IN LIVER DISEASE (2023)

Add to Collection

Review Gastroenterology & Hepatology

Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease

Karim Seif El Dahan et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a growing cause of hepatocellular carcinoma (HCC), and HCC surveillance is recommended for patients with cirrhosis from any cause and may be beneficial for high-risk subgroups with non-cirrhotic NAFLD. NAFLD-related HCC patients are more likely to have advanced stage cancer and poor outcomes due to suboptimal effectiveness of surveillance programs. This review summarizes current HCC surveillance guidelines, discusses challenges specific to NAFLD, and examines the effectiveness of current surveillance tools while suggesting future approaches to improve adherence.

CLINICAL AND MOLECULAR HEPATOLOGY (2023)

Add to Collection

Review Medicine, General & Internal

Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A Review

Weon Jang et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) refers to the accumulation of liver fat without specific causes. It ranges from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH), fibrosis, and NASH-related cirrhosis. Due to limitations of liver biopsy and the prevalence of NAFLD, non-invasive imaging methods such as ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) have rapidly developed for reliable diagnosis of hepatic steatosis. This review provides an overview of each imaging modality, with a focus on recent progress and current status of liver fat quantification.

DIAGNOSTICS (2023)

Add to Collection

Article Gastroenterology & Hepatology

TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models

Miriam Longo et al.

Summary: The study found that the co-presence of 3 at-risk variants, PNPLA3, TM6SF2, and MBOAT7, has a significant impact on the course of NAFLD in both patients and experimental models. It affects liver disease severity, LD accumulation, mitochondrial functionality, and metabolic reprogramming, leading to an increased risk of HCC.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease: Current Global Burden

Mohamed El-Kassas et al.

Summary: The global burden of chronic liver diseases, particularly nonalcoholic fatty liver disease (NAFLD), is changing and becoming the most common cause of liver diseases. Understanding the incidence and prevalence of NAFLD is crucial due to its significant economic burden and consequences. Immediate actions are needed to raise global awareness and address metabolic risk factors.

SEMINARS IN LIVER DISEASE (2022)

Add to Collection

Review Oncology

Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: Current knowledge and potential for therapeutics

Imaad Said et al.

Summary: The gut microbiome is closely connected to the liver and can influence liver diseases and carcinogenesis. Dysbiosis is associated with liver diseases and cancer through effects on intestinal permeability and the innate immune system. Therapeutics that modulate the microbiome show potential in improving liver diseases.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)

Add to Collection

Review Oncology

Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows

Federico Costante et al.

Summary: About one-fourth of adults globally suffer from nonalcoholic fatty liver disease (NAFLD), which is becoming a leading cause of chronic liver disease worldwide. NAFLD is a leading cause of hepatocellular carcinoma (HCC), and the tumor microenvironment (TME) in HCC patients is characterized by complex interactions and immune suppression. Treatment with immune checkpoint inhibitors (ICIs) may not be as effective in patients with NAFLD-related HCC, while the addition of an angiogenesis inhibitor shows better results. Future strategies should consider novel biomarkers and modulation of gut microbiota to improve personalized medicine and response to ICIs in NAFLD-related HCC.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

Use of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis: A Systematic Review and Meta-Analysis

Erin Wolf et al.

Summary: The study found that HCC surveillance is underused in clinical practice, especially among patients with alcohol-associated or NASH-related cirrhosis and those not followed in subspecialty gastroenterology clinics. Interventions such as provider education, inreach including reminder systems, and population health outreach efforts can significantly increase HCC surveillance.

HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease

Monica Pons et al.

Summary: This study aimed to explore the prevalence of portal hypertension in different etiologies of patients with cACLD and develop classification rules based on LSM. The prevalence of portal hypertension was high in most etiologies except for NASH patients, especially obese ones. LSM >= 25 kPa was sufficient to diagnose CSPH in most etiologies, except for obese NASH patients.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies

Umar Hayat et al.

Summary: Regular coffee consumption is significantly associated with a reduced risk of NAFLD and liver fibrosis development, benefiting liver health. However, further epidemiological studies are needed to confirm this conclusion.

ANNALS OF HEPATOLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Effect of green-Mediterranean diet on intrahepatic fat: the DIRECT PLUS randomised controlled trial

Anat Yaskolka Meir et al.

Summary: The study found that a green-Mediterranean diet (MED) is more effective in reducing non-alcoholic fatty liver disease (NAFLD), with a greater decrease in intrahepatic fat (IHF) content, by further restricting red/processed meat and increasing intake of green plants and polyphenols. This healthy dietary strategy shows promising results in reducing IHF and decreasing NAFLD prevalence.

GUT (2021)

Add to Collection

Review Nutrition & Dietetics

The Association between Diet and Hepatocellular Carcinoma: A Systematic Review

Elena S. George et al.

Summary: There is an association between diet and the development of HCC, with specific dietary patterns and nutrient intake showing correlation with reduced risk of HCC. Further quantitative research in different populations is needed to investigate the relationship between diet and HCC risk.

NUTRIENTS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease

Ramy Younes et al.

Summary: This study compared various non-invasive scoring systems in identifying risk and predicting long-term outcomes for patients with non-alcoholic fatty liver disease. NFS, HFS, and FIB-4 outperformed APRI and BARD in both cross-sectional identification of fibrosis and prediction of long-term outcomes, making them useful tools for clinical management of NAFLD patients at increased risk of fibrosis and liver-related complications or death.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Review Oncology

The Current View of Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma

Tomomi Kogiso et al.

Summary: The incidence of NAFLD-related HCC is increasing, emphasizing the need for effective screening. Revised guidelines in Japan propose new management and surveillance strategies for NAFLD/NASH. Advanced fibrosis and lifestyle-related diseases are associated with HCC development.

CANCERS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

Cristiana Bianco et al.

Summary: This study utilized polygenic risk scores (PRS) to investigate the causal relationship between hepatic fat and HCC, improving the accuracy of HCC detection and helping to stratify HCC risk in individuals with dysmetabolism. The PRS showed robust predictions for HCC in both high-risk individuals and the general population.

JOURNAL OF HEPATOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC

Paola Dongiovanni et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is the main contributor to chronic liver diseases globally, with potential progression from simple steatosis to nonalcoholic steatohepatitis (NASH) and eventually liver cancer. Various factors, including genetic and environmental factors, diet and lifestyle habits, can accelerate the worsening of the disease.

BIOMEDICINES (2021)

Add to Collection

Article Endocrinology & Metabolism

Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?

Miriam Longo et al.

Summary: NAFLD is a liver disease caused by mitochondrial abnormalities, which can be managed with strict dietary and physical exercise interventions, as well as novel pharmacological treatments to improve patient compliance. The study of mitochondrial dynamics shows promising perspectives for future NAFLD healthcare.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Add to Collection

Article Multidisciplinary Sciences

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister et al.

Summary: The study investigated the impact of NASH on immunotherapy response in HCC patients and found that NASH-HCC may be less responsive to immunotherapy. Aberrant T cell activation caused by NASH-related tissue damage led to impaired immune surveillance in HCC patients.

NATURE (2021)

Add to Collection

Article Oncology

A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?

Nardeen Eldafashi et al.

Summary: The study explores how genetic variations in immunoregulatory genes may impact the development of liver cancer in patients with NAFLD, both with and without cirrhosis. Results suggest that certain variations in genes such as PDCD1 may increase the risk of NAFLD-HCC development, independent of the presence of cirrhosis.

CANCERS (2021)

Add to Collection

Review Oncology

NAFLD-Associated HCC: Progress and Opportunities

Daniel Geh et al.

Summary: NAFLD-related HCC is becoming a major cause of HCC in Western countries, particularly in older patients with comorbidities. Advancements in understanding the drivers of NAFLD and HCC may lead to the development of clinically relevant biomarkers and targeted therapies for high-risk patients.

JOURNAL OF HEPATOCELLULAR CARCINOMA (2021)

Add to Collection

Article Medicine, Research & Experimental

A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis

Naoto Fujiwara et al.

Summary: The blood-based PLSec-AFP can accurately stratify patients with advanced liver fibrosis for long-term HCC risk and thereby guide risk-based tailored HCC screening.

MED (2021)

Add to Collection

Article Oncology

Composite Score of Healthy Lifestyle Factors and Risk of Hepatocellular Carcinoma: Findings from a Prospective Cohort Study

Hung N. Luu et al.

Summary: This study demonstrates that adopting a healthy lifestyle can reduce the risk of developing HCC, especially for individuals without hepatitis B virus and hepatitis C virus infections. Therefore, emphasizing a comprehensive lifestyle modification strategy is crucial for primary prevention of HCC.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

Add to Collection

Article Multidisciplinary Sciences

NASH limits anti-tumour surveillance in immunotherapy-treated HCC

Dominik Pfister et al.

Summary: The text discusses the impact of NASH on the development of HCC and the effect of immunotherapy, revealing the accumulation of exhausted and unconventionally activated CD8(+)PD1(+) T cells in NASH-affected livers. In preclinical models of NASH-induced HCC, anti-PD1 treatment led to an increase in HCC, with CD8(+) T cells contributing to this increase.

NATURE (2021)

Add to Collection

Article Gastroenterology & Hepatology

GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

Jan Best et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease

Fasiha Kanwal et al.

HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

Non-enhanced magnetic resonance imaging as a surveillance tool for hepatocellular carcinoma: Comparison with ultrasound

Hyo Jung Park et al.

JOURNAL OF HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study

Philip N. Newsome et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Review Oncology

Statin Use and the Risk of Hepatocellular Carcinoma: A Meta-Analysis of Observational Studies

Md. Mohaimenul Islam et al.

CANCERS (2020)

Add to Collection

Article Oncology

Statin Use Decreases the Incidence of Hepatocellular Carcinoma: An Updated Meta-Analysis

Antonio Facciorusso et al.

CANCERS (2020)

Add to Collection

Article Medicine, General & Internal

Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality

Tracey G. Simon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Review Medicine, General & Internal

MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD

Marica Meroni et al.

EBIOMEDICINE (2020)

Add to Collection

Article Gastroenterology & Hepatology

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates

Zobair Younossi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

ADAPT: An Algorithm Incorporating PRO-C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis

Samuel J. Daniels et al.

HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Hepatocellular Carcinoma Is Associated With Gut Microbiota Profile and Inflammation in Nonalcoholic Fatty Liver Disease

Francesca Romana Ponziani et al.

HEPATOLOGY (2019)

Add to Collection

Article Cell Biology

Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease

Xingtong Shen et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Add to Collection

Review Gastroenterology & Hepatology

From NASH to HCC: current concepts and future challenges

Quentin M. Anstee et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)

Add to Collection

Article Genetics & Heredity

Gene Expression and DNA Methylation Alterations During Non-alcoholic Steatohepatitis-Associated Liver Carcinogenesis

Kostiantyn Dreval et al.

FRONTIERS IN GENETICS (2019)

Add to Collection

Article Oncology

NAFLD-Associated Comorbidities in Advanced Stage HCC Do Not Alter the Safety and Efficacy of Yttrium-90 Radioembolization

Clemens Schotten et al.

LIVER CANCER (2019)

Add to Collection

Review Gastroenterology & Hepatology

Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

Laurent Castera et al.

GASTROENTEROLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study

Sebastian E. Baumeister et al.

JOURNAL OF HEPATOLOGY (2019)

Add to Collection

Article Gastroenterology & Hepatology

Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease

Donghee Kim et al.

LIVER INTERNATIONAL (2019)

Add to Collection

Article Gastroenterology & Hepatology

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

Marie Boyle et al.

JHEP REPORTS (2019)

Add to Collection

Article Gastroenterology & Hepatology

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis

Kristina Tzartzeva et al.

GASTROENTEROLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero et al.

HEPATOLOGY (2018)

Add to Collection

Article Oncology

Association Between Aspirin Use and Risk of Hepatocellular Carcinoma

Tracey G. Simon et al.

JAMA ONCOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Metastasis-Associated Lung Adenocarcinoma Transcript 1 as a Common Molecular Driver in the Pathogenesis of Nonalcoholic Steatohepatitis and Chronic Immune Mediated Liver Damage

Silvia Sookoian et al.

HEPATOLOGY COMMUNICATIONS (2018)

Add to Collection

Article Oncology

Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation

Pushkar Malakar et al.

CANCER RESEARCH (2017)

Add to Collection

Article Gastroenterology & Hepatology

Plasma DNA methylation: a potential biomarker for stratification of liver fibrosis in non-alcoholic fatty liver disease

Timothy Hardy et al.

GUT (2017)

Add to Collection

Article Gastroenterology & Hepatology

The PNPLA3 I148M Variant Modulates the Fibrogenic Phenotype of Human Hepatic Stellate Cells

Francesca Virginia Bruschi et al.

HEPATOLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

TM6SF2 rs58542926 Impacts Lipid Processing in Liver and Small Intestine

Elizabeth A. O'Hare et al.

HEPATOLOGY (2017)

Add to Collection

Article Nutrition & Dietetics

Coffee Consumption and Risk of Biliary Tract Cancers and Liver Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies

Justyna Godos et al.

NUTRIENTS (2017)

Add to Collection

Review Medicine, General & Internal

Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis

Oliver John Kennedy et al.

BMJ OPEN (2017)

Add to Collection

Article Gastroenterology & Hepatology

Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis

Nicolas Goossens et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)

Add to Collection

Article Oncology

The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level Results From the Global Burden of Disease Study 2015

Tomi Akinyemiju et al.

JAMA ONCOLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals

Benedetta Donati et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Review Gastroenterology & Hepatology

Proposal of a new diagnostic algorithm for hepatocellular carcinoma based on the Japanese guidelines but adapted to the Western world for patients under surveillance for chronic liver disease

Matteo Renzulli et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)

Add to Collection

Article Oncology

miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma

Junwei Lian et al.

ONCOTARGET (2016)

Add to Collection

Article Gastroenterology & Hepatology

Clinical Patterns of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: A Multicenter Prospective Study

Fabio Piscaglia et al.

HEPATOLOGY (2016)

Add to Collection

Article Oncology

LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway

Shi-Peng Li et al.

ONCOTARGET (2016)

Add to Collection

Review Medicine, General & Internal

Circulating microRNAs as Potential Biomarkers in Non-Alcoholic Fatty Liver Disease and Hepatocellular Carcinoma

Marta B. Afonso et al.

JOURNAL OF CLINICAL MEDICINE (2016)

Add to Collection

Article Gastroenterology & Hepatology

Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis

Eduardo Vilar-Gomez et al.

GASTROENTEROLOGY (2015)

Add to Collection

Letter Gastroenterology & Hepatology

Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance

Quentin M. Anstee et al.

JOURNAL OF HEPATOLOGY (2015)

Add to Collection

Article Genetics & Heredity

A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis

Stephan Buch et al.

NATURE GENETICS (2015)

Add to Collection

Article Pharmacology & Pharmacy

Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion

Yuting Wu et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)

Add to Collection

Review Genetics & Heredity

The Landscape of long noncoding RNA classification

Georges St Laurent et al.

TRENDS IN GENETICS (2015)

Add to Collection

Article Gastroenterology & Hepatology

Association Between the PNPLA3 (rs738409 C>G) Variant and Hepatocellular Carcinoma: Evidence From a Meta-Analysis of Individual Participant Data

Eric Trepo et al.

HEPATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team

Jessica Dyson et al.

JOURNAL OF HEPATOLOGY (2014)

Add to Collection

Article Genetics & Heredity

Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease

Julia Kozlitina et al.

NATURE GENETICS (2014)

Add to Collection

Review Gastroenterology & Hepatology

Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis

Siddharth Singh et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

Add to Collection

Article Gastroenterology & Hepatology

Liver resection in obese patients: results of a case-control study

Luca Vigano et al.

HPB (2011)

Add to Collection

Article Endocrinology & Metabolism

Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes

Mariana Lazo et al.

DIABETES CARE (2010)

Add to Collection

Article Biochemistry & Molecular Biology

Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

C. Coulouarn et al.

ONCOGENE (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.